COVID-19: Trouble as fire guts biggest vaccine maker in India

COVID-19: Trouble as fire guts biggest vaccine maker in India

- The fight against the deadly Coronavirus in India may have suffered a minor setback

- This is because there was a fire outbreak at a new facility of Serum Institute on Thursday, January 21,

- The affected site belonged to the biggest and largest producer of India approved vaccine, Covishield

PAY ATTENTION: Click “See First” under the “Following” tab to see News on your Facebook News Feed!

The assault against the dreaded Coronavirus in India may have witnessed a bit of a slowing down over a recent incident in one of its vaccine-producing facility.

This follows as there was a fire incident, according to National News, in one of the new sites of India's Serum Institute, an organisation that has been at the forefront of vaccine production in India.

The incident said to have occurred on Thursday, January 21 at a new site in Pune, Western India has already claimed 5 lives in this wake.

Read also

COVID-19: Report reveals Lagos may run out of oxygen as infections escalate

Tragedy as fire torches facility of world biggest vaccine producer
COVID-19: Trouble as fire guts biggest vaccine maker in India Photo Credit: The National News
Source: UGC

In early January, the government of India had given approval for two vaccines to be administered.

One of the vaccines, Covaxin, is produced by local company Bharat Biotech while the other vaccine, Covishield is handled by the Serum Institute, the victim of the fire outbreak that torched their site.

Reacting to the incident, an unnamed official of the affected company said that the incident will not in any way affect the production of the COVID-19 vaccine.

In what is a huge breakthrough in the virus fight, India had commenced arguably one of the biggest vaccine drives in the world on Saturday, January 16.

The demand for the Serum institute vaccine has since surged just as plans are underway to supply 200 million doses to WHO-backed covax to complement her vaccine distribution drive to poor and developing nations.

Plans are also in place to have Covishield, developed by the University of Oxford and AstraZeneca, delivered to South Asia in 20 million doses, with South America, Latin America and Africa in line to receive the vaccine.

Read also

Nigerian governor rejects COVID-19 vaccine, says it is meant to kill people

PAY ATTENTION: Install our latest app for Android, read best news on Nigeria’s #1 news app

Meanwhile, had earlier reported how the Governor of Kogi, Yahaya Bello, had passionately rejected coronavirus vaccine.

The Cable reports that while addressing a crowd, Bello doubted the authenticity of the vaccine.

He was quoted to have claimed that the vaccine wants to be used to introduce a disease that will kill people.

How I treated Covid 19 from my house - Nigerian man in America reveals | Legit TV

Source: Legit

Online view pixel